T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
AXIS Capital
AXS
$7.36B
| $378M | 0.05% |
6,331,132
+812,096
| +15% | +$47.2M |
|
|
TXNM
327
TXNM Energy Inc
TXNM
$5.91B
| $377M | 0.05% |
7,402,748
+449,729
| +6% | +$21.4M |
|
328
FirstEnergy
FE
$27B
| $377M | 0.05% |
8,796,161
-2,323,832
| -21% | -$97.6M |
|
329
AbbVie
ABBV
$438B
| $376M | 0.05% |
5,176,070
+2,326,510
| +82% | +$183M |
|
330
Martin Marietta Materials
MLM
$32.7B
| $371M | 0.05% |
1,614,214
-65,811
| -4% | -$14.3M |
|
331
Banco Santander Chile
BSAC
$16.3B
| $371M | 0.05% |
12,407,892
+1,170,746
| +10% | +$34M |
|
|
CTRA
332
DELISTED
Coterra Energy
CTRA
| $371M | 0.05% |
16,158,608
-2,935,782
| -15% | -$74.7M |
|
333
T-Mobile US
TMUS
$189B
| $369M | 0.05% |
4,979,435
-744,589
| -13% | -$55.3M |
|
|
PSB
334
DELISTED
PS Business Parks, Inc.
PSB
| $366M | 0.05% |
2,173,816
+11,207
| +0.5% | +$1.79M |
|
|
SEM
335
DELISTED
Select Medical
SEM
| $366M | 0.05% |
42,794,703
+305,410
| +0.7% | +$2.41M |
|
336
Flowers Foods
FLO
$1.5B
| $362M | 0.05% |
15,572,599
+179,651
| +1% | +$3.98M |
|
337
Nomad Foods
NOMD
$1.61B
| $361M | 0.05% |
16,897,346
+3,375,054
| +25% | +$70.8M |
|
338
Regency Centers
REG
$13.9B
| $361M | 0.05% |
5,407,470
-132,362
| -2% | -$8.89M |
|
339
Pool Corp
POOL
$7.29B
| $358M | 0.05% |
1,872,864
+56,797
| +3% | +$10.3M |
|
|
CLR
340
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $356M | 0.05% |
8,462,357
+512,106
| +6% | +$21.9M |
|
341
Vulcan Materials
VMC
$36.5B
| $355M | 0.05% |
2,585,013
-140,698
| -5% | -$18M |
|
342
PG&E
PCG
$38.1B
| $352M | 0.05% |
15,340,014
-1,375,360
| -8% | -$27.6M |
|
|
LLL
343
DELISTED
L3 Technologies, Inc.
LLL
| $352M | 0.05% |
1,434,029
-130,455
| -8% | -$30.5M |
|
|
BPMC
344
DELISTED
Blueprint Medicines
BPMC
| $347M | 0.05% |
3,681,291
+305,682
| +9% | +$25.2M |
|
345
CubeSmart
CUBE
$9.3B
| $347M | 0.05% |
10,366,989
+2,382,832
| +30% | +$78.2M |
|
|
SBNY
346
DELISTED
Signature Bank
SBNY
| $346M | 0.05% |
2,866,884
-305,765
| -10% | -$37.8M |
|
347
EastGroup Properties
EGP
$10.9B
| $346M | 0.05% |
2,979,616
+18,209
| +0.6% | +$2.06M |
|
348
Western Alliance Bancorporation
WAL
$8.96B
| $344M | 0.05% |
7,702,713
+296,647
| +4% | +$13.2M |
|
349
Amphenol
APH
$211B
| $344M | 0.05% |
14,361,612
+5,844,216
| +69% | +$141M |
|
|
ACC
350
DELISTED
American Campus Communities, Inc.
ACC
| $343M | 0.05% |
7,426,127
+508,366
| +7% | +$23.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.